Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database

Surgery (United States)

Volumn 156, Issue 2, 2014, Pages 298-304

  Bartlett, Edmund K ^a   Roses, Robert E ^a   Kelz, Rachel R ^a   Drebin, Jeffrey A ^a   Fraker, Douglas L ^a   Karakousis, Giorgos C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONFERENCE PAPER; DATA BASE; DIABETES MELLITUS; FEMALE; FUNCTIONAL STATUS; GROUPS BY AGE; HEALTH CARE QUALITY; HEMATOCRIT; HIGH RISK PATIENT; HUMAN; HYPERBILIRUBINEMIA; HYPERTENSION; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PANCREAS RESECTION; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; SPLENECTOMY; STOMACH CANCER; SURGEON; SURGICAL MORTALITY; SURGICAL RISK; TOTAL STOMACH RESECTION; WEIGHT REDUCTION;

AGED; DATABASES, FACTUAL; FEMALE; GASTRECTOMY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MORBIDITY; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PATIENT SELECTION; QUALITY IMPROVEMENT; RISK FACTORS; SOCIETIES, MEDICAL; STOMACH NEOPLASMS; UNITED STATES;

EID: 84904249721     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.03.022     Document Type: Conference Paper

References (27)

1. J. Ferlay, I. Soerjomataram, and M. Ervik et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] 2013 International Agency for Research on Cancer Lyon, France Available from: http://globocan.iarc.fr. Accessed April 7, 2014
2. N.A. Howlader, M. Krapcho, N. Neyman, R. Aminou, S.F. Altekruse, and C.L. Kosary et al. SEER Cancer Statistics Review, 1975-2010 (Vintage 2010 Populations) 2012 National Cancer Institute Bethesda, MD Available from http://seer.cancer.gov/csr/1975-2010-pops09/
3. H.H. Hartgrink, C.J. van de Velde, and H. Putter et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial J Clin Oncol 22 2004 2069 2077
4. M. Sasako, T. Sano, and S. Yamamoto et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 2008 453 462
5. W. Yu, G.S. Choi, and H.Y. Chung Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer Br J Surg 93 2006 559 563
6. D. Cunningham, W.H. Allum, and S.P. Stenning et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
7. A. Cuschieri, P. Fayers, and J. Fielding et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group Lancet 347 1996 995 999
8. NCCN Clinical Practice Guidelines in Oncology - Gastric Cancer - Version 2.2013. National Comprehensive Cancer Network; Fort Washington, PA. Available from: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#gastric.
9. M. Dhir, L.M. Smith, and F. Ullrich et al. A preoperative nomogram to predict the risk of perioperative mortality following gastric resections for malignancy J Gastrointest Surg 16 2012 2026 2036
10. F. Bozzetti, E. Marubini, and G. Bonfanti et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group Ann Surg 226 1997 613 620
11. I. Gockel, S. Pietzka, and U. Gonner et al. Subtotal or total gastrectomy for gastric cancer: impact of the surgical procedure on morbidity and prognosis - analysis of a 10-year experience Langenbecks Arch Surg 390 2005 148 155
12. E.M. Grossmann, W.E. Longo, and K.S. Virgo et al. Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers Surgery 131 2002 484 490
13. J.S. Macdonald, S.R. Smalley, and J. Benedetti et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
14. J.A. Ajani, P.F. Mansfield, and C.H. Crane et al. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome J Clin Oncol 23 2005 1237 1244
15. J.A. Ajani, K. Winter, and G.S. Okawara et al. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response J Clin Oncol 24 2006 3953 3958
16. F. De Vita, F. Giuliani, and M. Orditura et al. Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) Ann Oncol 18 2007 1354 1358
17. S. Sakuramoto, M. Sasako, and T. Yamaguchi et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 2007 1810 1820
18. User Guide for the 2010 Participant Use Data File. American College of Surgeons National Surgical Quality Improvement Program 2011. Available from: http://site.acsnsqip.org/wp-content/uploads/2012/03/2010-User-Guide-FINAL.pdf.
19. M. Shiloach, S.K. Frencher Jr., and J.E. Steeger et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program J Am Coll Surg 210 2009 6 16
20. E.K. Bartlett, C. Meise, and R.E. Roses et al. Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database Ann Surg Oncol 21 2014 1494 1500
21. D.Y. Greenblatt, K.J. Kelly, and V. Rajamanickam et al. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy Ann Surg Oncol 18 2011 2126 2135
22. J.J. Bonenkamp, I. Songun, and J. Hermans et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Lancet 345 1995 745 748
23. P.J. Karanicolas, E.B. Elkin, and L.M. Jacks et al. Staging laparoscopy in the management of gastric cancer: a population-based analysis J Am Coll Surg 213 2011 644 651 651 e1
24. J.J. Mezhir, M.A. Shah, and L.M. Jacks et al. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients Ann Surg Oncol 17 2010 3173 3180
25. J.J. Mezhir, L.H. Tang, and D.G. Coit Neoadjuvant therapy of locally advanced gastric cancer J Surg Oncol 101 2010 305 314
26. U. Fedeli, E. Schievano, and M. Lisiero Mortality after esophageal and gastric cancer resection World J Surg 36 2012 2630 2636
27. P.J. Kneuertz, H.A. Pitt, and K.Y. Bilimoria et al. Risk of morbidity and mortality following hepato-pancreato-biliary surgery J Gastrointest Surg 16 2012 1727 1735